The cannabis industry—encompassing both intoxicating THC-based and non-psychoactive CBD-based products—represents one area of the licensing business that has not seen much of a decline in new deals during the coronavirus crisis. In fact, the oft-touted benefits of cannabis-based products, both ingestible and topical, for stress reduction and general wellness are likely bigger selling points during […]